Your Cart

Inside the RE2O treatment: Where Human Tissue Comes In

Inside the RE2O treatment: Where Human Tissue Comes In

Nov 20, 2026

Dr. Mohamed Ahmed Ismail, known as Dr Mo, is a Dubai-based physician working in aesthetics, regenerative medicine, and longevity. In this conversation with Tru & Beyond, he explains why RE2O is drawing attention in Korea, why he chose it for my skin, and what he looks for in the months after treatment.

1. Dr Mo, why is RE2O getting so much attention in Korea? What’s genuinely new about it, and how much of the excitement is ahead of the science?

Korea is always moving fast when it comes to aesthetics. Sometimes the excitement comes before the science, and sometimes there’s something genuinely interesting behind it.

What caught my attention with RE2O is the concept.

For years, we’ve been focusing on stimulating collagen, improving hydration, or replacing lost volume. But I believe we also need to pay more attention to the environment where our skin cells actually live.

That’s where the extracellular matrix comes in.

RE2O is interesting because it introduces human-derived extracellular matrix components into the skin rather than simply adding volume or hydration.

For me, that’s a different way of thinking about skin rejuvenation.

Of course, I don’t believe in calling every new treatment revolutionary. We have promising early results, but we still need more clinical evidence.

I’m interested in the science behind RE2O, not just the excitement around it.

2. We hear that it works on the skin’s “support structure.” What does that actually mean? What happens beneath the surface, and how is that different from other skin boosters or collagen stimulators?

I always say that healthy skin is not just about having healthy cells. It’s also about having a healthy environment around those cells.

Think about it. You can have perfectly healthy cells, but if the environment supporting them is damaged or deteriorating, they may not function the way they should.

That’s exactly why the extracellular matrix is so important.

It’s not just something that holds our skin together. It also influences how cells communicate, respond, and maintain the tissue.

With aging, we lose some of that structural organization and biological support.

Most skin boosters focus on hydration, while collagen stimulators encourage the skin to produce more collagen.

RE2O is different because we’re introducing components of the extracellular matrix itself.

The idea is to provide a biological structure that may support the surrounding tissue and its remodeling process.

Does that mean we’re rebuilding young skin? Not necessarily. We still need research to demonstrate exactly what happens after injection.

But I find the concept very interesting because we’re starting to look beyond the cells and consider the environment they depend on.

3. You’ve treated my skin—what made you choose RE2O for me? What can it address particularly well, and what can’t it fix?

You know, when I look at someone’s face, I don’t see wrinkles first. I look at the quality of the tissue and try to understand what’s happening underneath.

Every face ages differently.

Some people lose volume, others lose elasticity, and some have relatively good facial structure but their skin quality starts changing.

In your case, I wasn’t trying to change your features or add unnecessary volume.

I wanted to work on improving your skin quality while keeping everything looking natural.

That’s why I considered RE2O.

I see potential for improving skin texture, fine lines, and overall dermal quality, although the clinical evidence is still developing.

But I would never tell someone that RE2O can fix everything.

If you’ve lost significant facial fat, have major skin laxity, or have structural changes in deeper facial layers, we need to address those problems differently.

That’s actually the philosophy behind my layering approach to biological aesthetics.

We have to understand which layer is aging before deciding how to treat it.

4. How do we distinguish an early glow from a lasting improvement in skin quality? What should I notice over the next few months, and how would you measure whether it’s worked?

I always tell my patients not to judge a regenerative treatment by what they see immediately after the injection.

That early glow can be beautiful, but it might simply be hydration or temporary swelling.

What interests me more is what happens afterward.

Does your skin continue to improve? Does the texture feel better? Is there a noticeable difference in elasticity? And most importantly, does that improvement last?

Those are the questions I care about.

I usually prefer to assess the skin over several months rather than making conclusions after a few days.

We can use standardized photography, skin analysis, and measurements of elasticity, hydration, and dermal thickness where appropriate.

And I always listen to the patient. How does your skin feel? What changes have you noticed?

But I also want objective measurements because sometimes what we see and what is actually happening biologically are two different things.

For me, a good treatment should deliver a visible improvement, but a successful biological treatment should ideally demonstrate a meaningful and lasting improvement in tissue quality.

5. What does the research actually prove so far? Which benefits are well supported, and what do we still need to learn about repeat treatments and long-term results?

I think we need to be careful with the word proven, especially in regenerative medicine.

We have early clinical research showing encouraging improvements in skin-quality parameters, including a small randomized study evaluating RE2O combined with hyaluronic acid.

That’s a positive start.

But it’s important to understand that a small study with relatively short follow-up cannot answer everything.

We still don’t know enough about the long-term behavior of the material, the ideal number of sessions, or what happens when we repeat the treatment over several years.

And there’s another question that personally interests me.

Are we simply seeing a cosmetic improvement, or are we actually improving the biological environment of the skin?

Those are not necessarily the same thing.

I would love to see more research examining how the injected matrix interacts with fibroblasts, surrounding tissues, and the body’s natural remodeling mechanisms.

Because for me, the future of regenerative medicine is not just about achieving a result. It’s about understanding how and why that result happens.

6. What should patients understand about where the material comes from and its safety? How is it screened and processed, what are the risks, and who would you advise against having it?

First, I believe patients deserve to know exactly what we’re putting into their bodies.

RE2O comes from donated human skin tissue. It’s processed to remove cellular components while preserving parts of the extracellular matrix.

So it’s important to understand that this is not your own tissue.

The manufacturing process is designed to reduce biological risks, but we still need proper documentation of donor screening, tissue processing, and quality control.

And I always remind patients that biological doesn’t automatically mean risk-free.

We still have to consider infection, inflammation, allergic or immune reactions, nodules, and injection-related vascular complications.

I would be cautious with anyone who has an active infection, significant inflammation, poor healing capacity, or a medical condition that could increase the risks.

I also wouldn’t use a product unless I was satisfied with its documentation and regulatory status.

I’ve been working with biological treatments for many years, and one thing I’ve learned is that the more advanced the material, the more seriously we need to take patient selection and safety.

I don’t believe in using something simply because it’s new or popular.

If I can’t explain why a patient needs it, what benefit we reasonably expect, and what the risks are, then I shouldn’t be offering it.

Final Thoughts — Dr Mo

I’ve always believed that aging is much more complicated than losing collagen or developing wrinkles.

Our cells change, but so does the environment around them. The extracellular matrix, the blood supply, the immune response, and the communication between cells all play a role.

That’s why I believe the future of aesthetics will be more biological and more personalized.

RE2O is one of the interesting developments we’re seeing in that direction.

But I don’t want patients to think there’s one injection that can reverse aging. There isn’t.

What excites me is that we’re gradually learning how to work with the biology of our tissues rather than simply changing how they look.

And that’s really what biological aesthetics means to me.